About Aclaris (ACRS)
Aclaris Therapeutics, Inc., incorporated on July 13, 2012, is a physician-led, biopharmaceutical company focused on immuno-inflammatory diseases. The Company is focused on leveraging its experience in drug discovery and development and kinase inhibit... Read more
- USD1.44
- USD1.56
- USD1.44
- USD5.17
- -5.20%
- 18M
- 180.46k
- 1.16M
- 156M
- 1.05
- 14.20%
Stock News
2 hours ago
Foresight: Eye-Net, in Collaboration with Orange’s Mobile Application, Achieves 99% Detection Rate in French Urban Mobility Trials
Yahoo
2 hours ago
This early-warning indicator is telling the stock market that a recession is more likely
MarketWatch
6 hours ago
What If Mistras Isn't As Broken As It Looks?
SeekingAlpha
6 hours ago
Boeing: Leadership Changes And A Warning For The Bulls
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
